Reduced phospholipid breakdown in Alzheimer's brains: A 31P spectroscopy study

Psychopharmacology

Volumn 180, Issue 2, 2005, Pages 359-365

  Forlenza, Orestes V ^a   Wacker, Priscilla ^a   Nunes, Paula V ^a   Yacubian, Juliana ^a   Castro, Claudio C ^a   Otaduy, Maria C G ^a   Gattaz, Wagner F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alzheimer's disease; Dementia; Phosphodiester; Phospholipid; Phosphomonoester; Spectroscopy

Indexed keywords

ESTER DERIVATIVE; PHOSPHODIESTER; PHOSPHOLIPID; PHOSPHOLIPID DERIVATIVE; PHOSPHOMONOESTER; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; INSTRUMENTATION; MALE; MEMORY; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGY; ORIENTATION; OUTPATIENT; PHOSPHOLIPID METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; THINKING; VISION;

AGED; ALZHEIMER DISEASE; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHOSPHOLIPASES A; PHOSPHOLIPIDS;

EID: 21344461449     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-2168-8     Document Type: Article

References (39)

1. Blessed G, Tomlinson BE, Roth M (1969) The association between quantitative measures and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114:797-811
2. Blusztajn JK, Liscovitch M, Richardson UI (1987) Synthesis of acethylcholine from choline derived from phosphatidylcholine in a human neuronal cell line. Proc Natl Acad Sci U S A 84 (15):5474-5477
3. Bottino CMC, Almeida OP, Tamai S, Forlenza OV, Scalco MZ, Carvalho IAM (1999) Entrevista estruturada para diagnóstico de transtornos mentais em idosos - CAMDEX The Cambridge Examination for Mental Disorders of the Elderly. Cambridge University Press (Brazilian version, translated and adapted on behalf of the editors)
4. Bottomley PA, Cousins JP, Pendrey DL, Wagle WA, Hardy CJ, Eames FA et al (1992) Alzheimer dementia: quantification of energy metabolism and mobile phosphoesters with P-31 NMR spectroscopy. Radiology 183:695-699
5. 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia. Neurology 39(11):1423-1427
6. Brown GG, Garcia JH, Gdowski JW, Levine SR, Helpern JA (1993) Altered brain energy metabolism in demented patients with multiple subcortical ischemic lesions. Working hypotheses. Arch Neurol 50(4):384-8
7. Cuenod CA, Kaplan DB, Michot JL, Jehenson P, Leroy-Willig A, Forette F et al (1995) Phospholipid abnormalities in early Alzheimer's disease. In vivo phosphorus 31 magnetic resonance spectroscopy. Arch Neurol 52(1):89-94
8. 2. J Biol Chem 269:13057-13060
9. Eckert GP, Cairns NJ, Maras A, Gattaz WF, Muller WE (2000) Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease. Dement Geriatr Cogn Disord 11(4):181-186
10. 2 activation influences the processing and secretion of the amyloid precursor protein. Biochem Biophys Res Commun 197(1):292-297
11. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
12. 2 activity in schizophrenic patients: reduction after neuroleptic therapy. Biol Psychiatry 22:421-426
13. 2 activity in Alzheimer brains. Biol Psychiatry 37:13-17
14. 2 in schizophrenia. Schizophr Res 16:1-6
15. 2 activity in the brain and in platelets of patients with Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 246(3):129-131
16. 2 activity in Alzheimer's disease and mild cognitive impairment. J Neural Transm 111(5):591-601
17. 31P magnetic resonance spectroscopy of Alzheimer disease. Alzheimer Dis Assoc Disord 10(1):46-52
18. Hachinski VC, Iliff LD, Phil M, Zilhka E, Du Boullay GH, Mcallister VI et al (1975) Cerebral blood flow in dementia. Arch Neurol 32:632-637
19. Hodkinson HM (1972) Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing 1:233-238
20. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566-572
21. Klein J (2000) Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids. J Neural Transm 107(8-9):1027-1063
22. Lukiw WJ, Bazan NG (2000) Neuroinflammatory signaling upregulation in Alzheimer's disease. Neurochem Res 25(9-10):1173-1184
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34(7):939-944
24. Mulder C, Wahlund LO, Teerlink T, Blomberg M, Veerhuis R, Van Kamp GJ et al (2003) Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer's disease. J Neural Transm 110(8):949-955
25. Murphy DG, Bottomley PA, Salerno JA, DeCarli C, Mentis MJ, Grady CL et al (1993) An in vivo study of phosphorus and glucose metabolism in Alzheimer's disease using magnetic resonance spectroscopy and PET. Arch Gen Psychiatry 50(5):341-349
26. Ordidge RJ, Connely A, Lohman JA (1986) Image-selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy. J Magn Reson 66:283-294
27. Pettegrew JW, Kanagasabai P, Moossy J, Martinez J, Rao G, Boller F (1988) Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease. Arch Neurol 45:1093-1096
28. Pettegrew JW, Panchalingam K, Klunk WE, McClure RJ, Muenz LR (1994) Alterations of cerebral metabolism in probable Alzheimer's disease: a preliminary study. Neurobiol Aging 15(1):117-132
29. Pettegrew JW, Klunk WE, Kanal E, Panchalingam K, McClure RJ (1995) Changes in brain membrane phospholipid and high-energy phosphate metabolism precede dementia. Neurobiol Aging 16(6):973-975
30. 2 activity. J Neurochem 70(2):786-793
31. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, Goddard R (1986) CAMDEX: a standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149:698-709
32. 2 activity in rat hippocampus impairs short-and long-term memory formation. Psychopharmacology
33. Skinner ER, Watt C, Besson JAO, Best PV (1989) Lipid composition of different regions of the brain in patients with Alzheimer's disease. Biochem Soc Trans 17:213-214
34. 31P magnetic resonance spectroscopy in Alzheimer's and Pick's disease. Neurobiol Aging 14(1):85-92
35. Smith CD, Pettigrew LC, Avison MJ, Kirsch JE, Tinkhtman AJ, Schmitt FA et al (1995) Frontal lobe phosphorus metabolism and neuropsychological function in aging and in Alzheimer's disease. Ann Neurol 38(2):194-201
36. 2) is expressed in human brain astrocytes. Brain Res 637:97-105
37. 2 activity in the prefrontal cortex. Neurochem Int 37(1):17-31
38. Vanhamme L, van den Boogaart A, Van Huffel S (1997) Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129(1):35-43
39. 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism. Schizophr Res 58(2-3):117-122